Related Experiment Video
Updated: Mar 6, 2026

Methods for Detecting Cough and Airway Inflammation in Mice
Published on: August 2, 2024
Effectiveness of a cough management algorithm at the transitional phase from acute to chronic cough in Australian
Kerry-Ann F O'Grady1, Keith Grimwood2, Maree Toombs3,4,5
1Centre for Children's Health Research, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
Insights
A new cough management algorithm for children with persistent cough after acute respiratory infections (ARIs) aims to improve outcomes. This study compares the algorithm to usual care to reduce chronic cough and associated costs in pediatric patients.
Area of Science:
- Pediatrics
- Respiratory Medicine
- Clinical Trials
Background:
- Acute respiratory infections (ARIs) are a major cause of hospitalization in children.
- Recurrent ARIs increase the risk of chronic pulmonary disorders.
- Chronic cough (>4 weeks) post-ARI in children reduces quality of life and increases healthcare costs.
Purpose of the Study:
- To determine if a validated, evidence-based cough algorithm improves clinical outcomes in children with chronic cough post-ARI.
- To compare the effectiveness of early algorithm initiation versus usual care.
- To identify predictors of chronic cough and associated costs.
Main Methods:
- A multicenter, randomized controlled trial nested within a prospective cohort study.
- 750 children <15 years with ARI and cough enrolled; 214 with persistent cough at day 28 randomized.
- Primary outcome: time to cough resolution. Secondary outcomes: cost of illness, predictors of chronic cough.
Main Results:
- Data collection is ongoing; results are pending.
- The study is designed to provide robust evidence on the efficacy of the cough algorithm.
- Analysis will focus on time to cough resolution and economic impact.
Conclusions:
- The study aims to establish best-practice guidelines for managing chronic cough in children post-ARI.
- Findings will inform clinical decision-making and potentially reduce healthcare burden.
- This research addresses a significant pediatric health issue with potential long-term benefits.
Introduction:
Acute respiratory infections (ARIs) are leading causes of hospitalisation in Australian children and, if recurrent, are associated with increased risk of chronic pulmonary disorders later in life. Chronic (>4 weeks) cough in children following ARI is associated with decreased quality-of-life scores and increased health and societal economic costs. We will determine whether a validated evidence-based cough algorithm, initiated when chronic cough is first diagnosed after presentation with ARI, improves clinical outcomes in children compared with usual care.
Methods And Analysis:
A multicentre, parallel group, open-label, randomised controlled trial, nested within a prospective cohort study in Southeast Queensland, Australia, is underway. 750 children aged <15 years will be enrolled and followed weekly for 8 weeks after presenting with an ARI with cough. 214 children from this cohort with persistent cough at day 28 will be randomised to either early initiation of a cough management algorithm or usual care (107 per group). Randomisation is stratified by reason for presentation, site and total cough duration at day 28 (<6 and ≥6 weeks). Demographic details, risk factors, clinical histories, examination findings, cost-of-illness data, an anterior nasal swab and parent and child exhaled carbon monoxide levels (when age appropriate) are collected at enrolment. Weekly contacts will collect cough status and cost-of-illness data. Additional nasal swabs are collected at days 28 and 56. The primary outcome is time-to-cough resolution. Secondary outcomes include direct and indirect costs of illness and the predictors of chronic cough postpresentation.
Ethics And Dissemination:
The Children's Health Queensland (HREC/15/QRCH/15) and the Queensland University of Technology University (1500000132) Research Ethics Committees have approved the study. The study will inform best-practice management of cough in children.
Trial Registration Number:
ACTRN12615000132549.
More Related Videos
06:22Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
Published on: September 19, 2025
05:43Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
Published on: January 10, 2025
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-IV: Nursing Management
First, in...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: